August 31, 2016 1:19 AM ET

Biotechnology

Company Overview of Lumena Pharmaceuticals, Inc.

Key Executives for Lumena Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
There is no Key Executives data available.

Lumena Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert Alexander Ph.D. 18 RelationshipsZS Pharma, Inc.46
Edward T. Mathers 190 RelationshipsNew Enterprise Associates56
Howard E. Greene Jr. 32 RelationshipsTandem Diabetes Care, Inc.73
David R. Savello Ph.D. 38 RelationshipsPappas Capital, LLC70
View All Board Members

Lumena Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Compensation Committee Ph.D.Robert Alexander18 Relationships2 Executives
Nominating Committee Edward T. Mathers190 Relationships2 Executives
Corporate Governance Committee Edward T. Mathers190 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
380.3K
Bonus
264.6K
Total Short Term Compensation
478.0K
Total Value of Options
33.9M
Compensation as of Fiscal Year
Lumena Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Bone Therapeutics SA Appoints Benoît Champluvier as Chief Technology and Manufacturing Officer
August 30, 2016 5:00 AM ET
Adverum Biotechnologies, Inc. Announces Resignation of John P. McLaughlin as Member of the Board of Directors, Chairman and Member of the Audit Committee and Member of the Compensation and Nominating and Corporate Governance Committees of the Board, Effective as of August 31, 2016
August 29, 2016 8:44 PM ET
OncoCyte Corporation Announces Board Changes
August 29, 2016 8:15 PM ET
Leap Therapeutics, Inc. and Macrocure Ltd. Announce Management Changes
August 29, 2016 12:51 PM ET
FORMA Therapeutics, Inc. Appoints Karoline Shair as Vice President, Legal and Chief Intellectual Property Counsel
August 29, 2016 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Lumena Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.